Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
France
Centre Hospitalier Universitaire de Besançon, Besançon Centre Georges-François Leclerc (CGFL), Dijon Hôpital Franco-Britannique, Levallois-Perret Hôpital Nord Franche Comté, Montbéliard Age range
18 Years and older
Last updated December 2023